(PharmaNewsWire.Com, August 21, 2018 ) The global Prosthetic heart Valves market turned into worth USD 5.46 Billion in 2018 and anticipated to be growing at a CAGR of 12.9%, to attain USD 10.02 billion by 2023. A prosthetic heart valve can be a device this is planted in an incredibly affected person full of valve failures within the coronary heart or alternative coronary heart diseases that locations the affected person in threat of failure. They’re planted every as a pre-emptive treatment and a reactive treatment.
Change in lifestyle of people (+) Increase in patient awareness (+) Rise in prevalence of cardiac disorders (+) Technological advancements (+) Growing demand for minimally invasive cardiovascular surgeries (+) Stringent rules and regulations (-) High cost and risk associated with prosthetic heart valves (-) Get your customized report:
Market Segmentation
The Global Prosthetic heart Valves market is geographically segmented into
North America Europe Asia Pacific Latin America Middle East and Africa The Prosthetic heart Valves market is dominated by North America in 2016 with the region accounting for over a third of the general market share.
The leading players dominating the market include Corvia Medical, CardioKinetix, Biomerics LLC, Lepu Medical Technology, XELTIS BV, Comed BV, HLT, Meril Life Sciences, SYMETIS SA and Transcatheter Technologies GmbH.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
